<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37006244</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Perivascular adipose tissue promotes vascular dysfunction in murine lupus.</ArticleTitle><Pagination><StartPage>1095034</StartPage><MedlinePgn>1095034</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1095034</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1095034</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Patients with systemic lupus erythematosus (SLE) are at elevated risk for Q10 cardiovascular disease (CVD) due to accelerated atherosclerosis. Compared to heathy control subjects, lupus patients have higher volumes and densities of thoracic aortic perivascular adipose tissue (PVAT), which independently associates with vascular calcification, a marker of subclinical atherosclerosis. However, the biological and functional role of PVAT in SLE has not been directly investigated.</AbstractText><AbstractText Label="METHODS">Using mouse models of lupus, we studied the phenotype and function of PVAT, and the mechanisms linking PVAT and vascular dysfunction in lupus disease.</AbstractText><AbstractText Label="RESULTS AND DISCUSSION">Lupus mice were hypermetabolic and exhibited partial lipodystrophy, with sparing of thoracic aortic PVAT. Using wire myography, we found that mice with active lupus exhibited impaired endothelium-dependent relaxation of thoracic aorta, which was further exacerbated in the presence of thoracic aortic PVAT. Interestingly, PVAT from lupus mice exhibited phenotypic switching, as evidenced by "whitening" and hypertrophy of perivascular adipocytes along with immune cell infiltration, in association with adventitial hyperplasia. In addition, expression of UCP1, a brown/beige adipose marker, was dramatically decreased, while CD45-positive leukocyte infiltration was increased, in PVAT from lupus mice. Furthermore, PVAT from lupus mice exhibited a marked decrease in adipogenic gene expression, concomitant with increased pro-inflammatory adipocytokine and leukocyte marker expression. Taken together, these results suggest that dysfunctional, inflamed PVAT may contribute to vascular disease in lupus.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Shi, Goo, Kim, Kress, Ogbi, Mintz, Wu, Belin de Chantem&#xe8;le, Stepp, Long, Guha, Lee, Carbone, Annex, Hui, Kim and Weintraub.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goo</LastName><ForeName>Brandee</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kress</LastName><ForeName>Taylor C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogbi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mintz</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Hanping</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Radiology and Imaging, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belin de Chantem&#xe8;le</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stepp</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Xiaochun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guha</LastName><ForeName>Avirup</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbone</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annex</LastName><ForeName>Brian H</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hui</LastName><ForeName>David Y</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ha Won</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weintraub</LastName><ForeName>Neal L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F30 AG074640</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017667" MajorTopicYN="N">Adipocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001013" MajorTopicYN="N">Aorta, Thoracic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050197" MajorTopicYN="Y">Atherosclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiovascular disease</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">perivascular adipose tissue</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">vasorelaxation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>3</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37006244</ArticleId><ArticleId IdType="pmc">PMC10062185</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1095034</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC. Systemic lupus erythematosus. N Engl J Med (2011) 365:2110&#x2013;121. doi:&#xa0;10.1056/NEJMra1100359</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1100359</ArticleId><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Alamanos Y, Voulgari PV, Parassava M, Tsamandouraki K, Drosos AA. Survival and mortality rates of systemic lupus erythematosus patients in northwest greece. study of a 21-year incidence cohort. Rheumatology (2003) 42:1122&#x2013;3. doi:&#xa0;10.1093/rheumatology/keg291</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keg291</ArticleId><ArticleId IdType="pubmed">12923275</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas G, Mancini J, Jourde-Chiche N, Sarlon G, Amoura Z, Harl&#xe9; JR, et al. . Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis. Arthritis Rheum (2014) 66:2503&#x2013;11. doi:&#xa0;10.1002/art.38731</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38731</ArticleId><ArticleId IdType="pubmed">24910304</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels CM, Buhr KA, Goldberg JW, Bell CL, Visekruna M, Nekkanti S, et al. . Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol (2014) 41:680&#x2013;7. doi:&#xa0;10.3899/jrheum.13087410.1016/j.phrs.2022.106354</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.13087410.1016/j.phrs.2022.106354</ArticleId><ArticleId IdType="pmc">PMC3975689</ArticleId><ArticleId IdType="pubmed">24532834</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, et al. . Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the framingham study. Am J Epidemiol (1997) 145:408&#x2013;15. doi:&#xa0;10.1093/oxfordjournals.aje.a009122</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009122</ArticleId><ArticleId IdType="pubmed">9048514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH. Systemic lupus erythematosus and risk of cardiovascular disease results from the nurses&#x2019; health study. Arthritis Rheum (2009) 61:1396&#x2013;402. doi: 10.1002/art.24537</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24537</ArticleId><ArticleId IdType="pmc">PMC2909444</ArticleId><ArticleId IdType="pubmed">19790130</ArticleId></ArticleIdList></Reference><Reference><Citation>Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. . Traditional framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum (2001) 44:2331&#x2013;7. doi: 10.1002/1529-0131(200110)44:10&lt;2331::AID-ART395&gt;3.0.CO;2-I</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200110)44:10&lt;2331::AID-ART395&gt;3.0.CO;2-I</ArticleId><ArticleId IdType="pubmed">11665973</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundhun PK, Boodhoo KD, Long MY, Chen MH. Impact of antiphospholipid syndrome and/or systemic lupus erythematosus on the long-term adverse cardiovascular outcomes in patients after percutaneous coronary intervention: A systematic review and meta-analysis. Medicine (2016) 95:e3200. doi:&#xa0;10.1097/MD.0000000000003200</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000003200</ArticleId><ArticleId IdType="pmc">PMC4998416</ArticleId><ArticleId IdType="pubmed">27015221</ArticleId></ArticleIdList></Reference><Reference><Citation>Magder LS, Petri M. Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol (2012) 176:708&#x2013;19. doi: 10.1093/aje/kws130</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kws130</ArticleId><ArticleId IdType="pmc">PMC3571250</ArticleId><ArticleId IdType="pubmed">23024137</ArticleId></ArticleIdList></Reference><Reference><Citation>Tselios K, Gladman DD, Su J, Ace O, Urowitz MB. Evolution of risk factors for atherosclerotic cardiovascular events in systemic lupus erythematosus: A long-term prospective study. J Rheumatol (2017) 44:1841&#x2013;9. doi: 10.3899/jrheum.161121</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.161121</ArticleId><ArticleId IdType="pubmed">29093154</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Kaplan MJ. Cardiovascular disease in systemic lupus erythematosus: An update. Curr Opin Rheumatol (2018) 30:441&#x2013;8. doi:&#xa0;10.1097/BOR.0000000000000528</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000528</ArticleId><ArticleId IdType="pubmed">29870498</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight JS, Zhao W, Luo W, Subramanian V, O&#x2019;Dell AA, Yalavarthi S, et al. . Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest (2013) 123:2981&#x2013;93. doi:&#xa0;10.1172/JCI67390</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI67390</ArticleId><ArticleId IdType="pmc">PMC3696545</ArticleId><ArticleId IdType="pubmed">23722903</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Tse SM, Chan KL, Ho LY. Effect of the metabolic syndrome on organ damage and mortality in patients with systemic lupus erythematosus: A longitudinal analysis. Clin Exp Rheumatol (2018) 36:0389&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">29148424</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung CP, Long AG, Solus JF, Rho YH, Oeser A, Raggi P, et al. . Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus (2009) 18:799&#x2013;806. doi:&#xa0;10.1177/0961203309103582</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309103582</ArticleId><ArticleId IdType="pmc">PMC2707942</ArticleId><ArticleId IdType="pubmed">19578104</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon M, Skaggs BJ, Sahakian L, Grossman J, FitzGerald J, Ragavendra N, et al. . High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Ann Rheum Dis (2011) 70:1619&#x2013;24. doi:&#xa0;10.1136/ard.2010.142737</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2010.142737</ArticleId><ArticleId IdType="pmc">PMC3147230</ArticleId><ArticleId IdType="pubmed">21670088</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn BH, Louren&#xe7;o EV, McMahon M, Skaggs B, Le E, Anderson M, et al. . Pro-inflammatory high-density lipoproteins and atherosclerosis are induced in lupus-prone mice by a high-fat diet and leptin. Lupus (2010) 19:913&#x2013;7. doi: 10.1177/0961203310364397</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203310364397</ArticleId><ArticleId IdType="pmc">PMC3159424</ArticleId><ArticleId IdType="pubmed">20410156</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Alfonso MS, Gil-Ortega M, Aranguez I, Souza D, Dreifaldt M, Somoza B, et al. . Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe? Br J Pharmacol (2017) 174:3561&#x2013;72. doi: 10.1111/bph.13734</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13734</ArticleId><ArticleId IdType="pmc">PMC5610150</ArticleId><ArticleId IdType="pubmed">28150299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HW, Belin de Chantem&#xe8;le EJ, Weintraub NL. Perivascular adipocytes in vascular disease. Arterioscler Thromb Vasc Biol (2019) 39:2220&#x2013;7. doi: 10.1161/ATVBAHA.119.312304</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.119.312304</ArticleId><ArticleId IdType="pmc">PMC6812617</ArticleId><ArticleId IdType="pubmed">31510794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HW, Shi H, Winkler MA, Lee R, Weintraub NL. Perivascular adipose tissue and vascular Perturbation/Atherosclerosis. Arterioscler Thromb Vasc Biol (2020) 40:2569&#x2013;76. doi: 10.1161/ATVBAHA.120.312470</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.312470</ArticleId><ArticleId IdType="pmc">PMC7577939</ArticleId><ArticleId IdType="pubmed">32878476</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancio J, Oikonomou EK, Antoniades C. Perivascular adipose tissue and coronary atherosclerosis. Heart (2018) 104:1654&#x2013;62. doi: 10.1136/heartjnl-2017-312324</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2017-312324</ArticleId><ArticleId IdType="pubmed">29853488</ArticleId></ArticleIdList></Reference><Reference><Citation>Horimatsu T, Patel AS, Prasad R, Reid LE, Benson TW, Zarzour A, et al. . Remote effects of transplanted perivascular adipose tissue on endothelial function and atherosclerosis. Cardiovasc Drugs Ther (2018) 32:503&#x2013;10. doi: 10.1007/s10557-018-6821-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-018-6821-y</ArticleId><ArticleId IdType="pmc">PMC6292666</ArticleId><ArticleId IdType="pubmed">30097828</ArticleId></ArticleIdList></Reference><Reference><Citation>Shields KJ, Barinas-Mitchell E, Gingo MR, Tepper P, Goodpaster BH, Kao AH, et al. . Perivascular adipose tissue of the descending thoracic aorta is associated with systemic lupus erythematosus and vascular calcification in women. Atherosclerosis (2013) 231:129&#x2013;35. doi: 10.1016/j.atherosclerosis.2013.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2013.09.004</ArticleId><ArticleId IdType="pmc">PMC3831349</ArticleId><ArticleId IdType="pubmed">24125423</ArticleId></ArticleIdList></Reference><Reference><Citation>Shields KJ, el Khoudary SR, Ahearn JM, Manzi S. Association of aortic perivascular adipose tissue density with aortic calcification in women with systemic lupus erythematosus. Atherosclerosis (2017) 262:55&#x2013;61. doi: 10.1016/j.atherosclerosis.2017.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2017.04.021</ArticleId><ArticleId IdType="pubmed">28521185</ArticleId></ArticleIdList></Reference><Reference><Citation>Roldan LP, Roldan PC, Sibbitt WL, Qualls CR, Ratliff MD, Roldan CA. Aortic adventitial thickness as a marker of aortic atherosclerosis, vascular stiffness, and vessel remodeling in systemic lupus erythematosus. Clin Rheumatol (2021) 40:1843&#x2013;52. doi: 10.1007/s10067-020-05431-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05431-7</ArticleId><ArticleId IdType="pubmed">33025269</ArticleId></ArticleIdList></Reference><Reference><Citation>Thacker SG, Duquaine D, Park J, Kaplan MJ. Lupus-prone new Zealand Black/New Zealand white F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells. Lupus (2010) 19:288&#x2013;99. doi: 10.1177/0961203309353773</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309353773</ArticleId><ArticleId IdType="pmc">PMC3151666</ArticleId><ArticleId IdType="pubmed">20068018</ArticleId></ArticleIdList></Reference><Reference><Citation>Furumoto Y, Smith CK, Blanco L, Zhao W, Brooks SR, Thacker SG, et al. . Tofacitinib ameliorates murine lupus and its associated vascular dysfunction. Arthritis Rheumatol (2017) 69:148&#x2013;60. doi: 10.1002/art.39818</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39818</ArticleId><ArticleId IdType="pmc">PMC5195893</ArticleId><ArticleId IdType="pubmed">27429362</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Thacker SG, Hodgin JB, Zhang H, Wang JH, Park JL, et al. . The peroxisome proliferator-activated receptor &#x3b3; agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus. J Immunol (2009) 183:2729&#x2013;40. doi: 10.4049/jimmunol.0804341</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0804341</ArticleId><ArticleId IdType="pmc">PMC2765333</ArticleId><ArticleId IdType="pubmed">19620300</ArticleId></ArticleIdList></Reference><Reference><Citation>Goo B, Ahmadieh S, Zarzour A, Yiew NKH, Kim D, Shi H, et al. . Sex-dependent role of adipose tissue HDAC9 in diet-induced obesity and metabolic dysfunction. Cells (2022) 11:2698. doi:&#xa0;10.3390/cells11172698</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11172698</ArticleId><ArticleId IdType="pmc">PMC9454798</ArticleId><ArticleId IdType="pubmed">36078104</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiew NKH, Greenway C, Zarzour A, Ahmadieh S, Goo B, Kim D, et al. . Enhancer of zeste homolog 2 (EZH2) regulates adipocyte lipid metabolism independent of adipogenic differentiation: Role of apolipoprotein e. J Biol Chem (2019) 294:8577&#x2013;91. doi: 10.1074/jbc.RA118.006871</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.006871</ArticleId><ArticleId IdType="pmc">PMC6544862</ArticleId><ArticleId IdType="pubmed">30971429</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlenberg JM, Kaplan MJ. Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus. Annu Rev Med (2013) 64:249&#x2013;63. doi: 10.1146/annurev-med-060911-090007</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-060911-090007</ArticleId><ArticleId IdType="pmc">PMC4198172</ArticleId><ArticleId IdType="pubmed">23020882</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinzer AB, Shamburek RD, Lightbourne M, Muniyappa R, Brown RJ. Advanced lipoprotein analysis shows atherogenic lipid profile that improves after metreleptin in patients with lipodystrophy. J Endocr Soc (2019) 3:1503&#x2013;17. doi: 10.1210/js.2019-00103</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/js.2019-00103</ArticleId><ArticleId IdType="pmc">PMC6676079</ArticleId><ArticleId IdType="pubmed">31620670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain I, Patni N, Garg A. Lipodystrophies, dyslipidaemias and atherosclerotic vascular disease. Pathology (2019) 51:202&#x2013;12. doi: 10.1016/j.pathol.2018.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pathol.2018.11.004</ArticleId><ArticleId IdType="pmc">PMC6402807</ArticleId><ArticleId IdType="pubmed">30595509</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi EW, Lee M, Song JW, Kim K, Lee J, Yang J, et al. . Fas mutation reduces obesity by increasing IL-4 and IL-10 expression and promoting white adipose tissue browning. Sci Rep (2020) 10:12001. doi:&#xa0;10.1038/s41598-020-68971-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-68971-7</ArticleId><ArticleId IdType="pmc">PMC7371740</ArticleId><ArticleId IdType="pubmed">32686763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wueest S, Rapold RA, Schumann DM, Rytka JM, Schildknecht A, Nov O, et al. . Deletion of fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. J Clin Invest (2010) 120:191&#x2013;202. doi: 10.1172/JCI38388</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI38388</ArticleId><ArticleId IdType="pmc">PMC2798678</ArticleId><ArticleId IdType="pubmed">19955656</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H, Wu H, Winkler MA, Belin de Chantem&#xe8;le EJ, Lee R, Kim HW, et al. . Perivascular adipose tissue in autoimmune rheumatic diseases. Pharmacol Res (2022) 182:106354. doi:&#xa0;10.1016/j.phrs.2022.106354</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106354</ArticleId><ArticleId IdType="pubmed">35842184</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Xiong W, Zhao X, Fan Y, Guo Y, Garcia-Barrio M, et al. . Bmal1 in perivascular adipose tissue regulates resting-phase blood pressure through transcriptional regulation of angiotensinogen. Circulation (2018) 138:67&#x2013;79. doi: 10.1161/CIRCULATIONAHA.117.029972</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.029972</ArticleId><ArticleId IdType="pmc">PMC6030431</ArticleId><ArticleId IdType="pubmed">29371216</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon B, Nedergaard J. Brown adipose tissue: Function and physiological significance. Physiol Rev (2004) 84:277&#x2013;359. doi: 10.1152/physrev.00015.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00015.2003</ArticleId><ArticleId IdType="pubmed">14715917</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Villacorta L, Li R, Hamblin M, Xu W, Dou C, et al. . Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-&#x3b3; deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation (2012) 126:1067&#x2013;78. doi: 10.1161/CIRCULATIONAHA.112.104489</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.104489</ArticleId><ArticleId IdType="pmc">PMC3493564</ArticleId><ArticleId IdType="pubmed">22855570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Wei Y, Wang L, Wang X, Du X, Sun Z, et al. . Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease. Cardiovasc Diabetol (2011) 10:2. doi:&#xa0;10.1186/1475-2840-10-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2840-10-2</ArticleId><ArticleId IdType="pmc">PMC3032658</ArticleId><ArticleId IdType="pubmed">21226932</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem (2003) 278:45021&#x2013;6. doi: 10.1074/jbc.M307878200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M307878200</ArticleId><ArticleId IdType="pubmed">12944390</ArticleId></ArticleIdList></Reference><Reference><Citation>Takaoka M, Nagata D, Kihara S, Shimomura I, Kimura Y, Tabata Y, et al. . Periadventitial adipose tissue plays a critical role in vascular remodeling. Circ Res (2009) 105:906&#x2013;11. doi: 10.1161/CIRCRESAHA.109.199653</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.109.199653</ArticleId><ArticleId IdType="pubmed">19762682</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan XX, Ruan CC, Liu XY, Kong LR, Ma Y, Wu QH, et al. . Perivascular adipose tissue-derived stromal cells contribute to vascular remodeling during aging. Aging Cell (2019) 18:e12969. doi:&#xa0;10.1111/acel.12969</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12969</ArticleId><ArticleId IdType="pmc">PMC6612678</ArticleId><ArticleId IdType="pubmed">31087498</ArticleId></ArticleIdList></Reference><Reference><Citation>Takaoka M, Suzuki H, Shioda S, Sekikawa K, Saito Y, Nagai R, et al. . Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue. Arterioscler Thromb Vasc Biol (2010) 30:1576&#x2013;82. doi: 10.1161/ATVBAHA.110.207175</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.110.207175</ArticleId><ArticleId IdType="pubmed">20489168</ArticleId></ArticleIdList></Reference><Reference><Citation>Piacentini L, Vavassori C, Colombo GI. Trained immunity in perivascular adipose tissue of abdominal aortic aneurysm-a novel concept for a still elusive disease. Front Cell Dev Biol (2022) 10:886086. doi:&#xa0;10.3389/fcell.2022.886086</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.886086</ArticleId><ArticleId IdType="pmc">PMC9174671</ArticleId><ArticleId IdType="pubmed">35693946</ArticleId></ArticleIdList></Reference><Reference><Citation>Nosalski R, Guzik TJ. Perivascular adipose tissue inflammation in vascular disease. Br J Pharmacol (2017) 174:3496&#x2013;513. doi: 10.1111/bph.13705</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13705</ArticleId><ArticleId IdType="pmc">PMC5610164</ArticleId><ArticleId IdType="pubmed">28063251</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczy&#x144;ska A, Herman AP, Antushevich H, Bochenek J, Wojtulewicz K, Ziba DA. The influence of photoperiod on the action of exogenous leptin on gene expression of proinflammatory cytokines and their receptors in the thoracic perivascular adipose tissue (PVAT) in ewes. Mediators Inflammation (2019) 2019:7129476. doi:&#xa0;10.1155/2019/7129476</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/7129476</ArticleId><ArticleId IdType="pmc">PMC6875191</ArticleId><ArticleId IdType="pubmed">31780867</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>